These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 35536519

  • 1. Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring.
    Katz AWK, Balán IC, Reddy K, Etima J, Weber K, Tauya T, Atujuna M, Scheckter R, Ngure K, Soto-Torres L, Mgodi N, Palanee-Phillips T, Baeten JM, van der Straten A.
    AIDS Behav; 2022 Nov; 26(11):3607-3619. PubMed ID: 35536519
    [Abstract] [Full Text] [Related]

  • 2. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial.
    Naidoo K, Mansoor LE, Katz AWK, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET.
    J Acquir Immune Defic Syndr; 2021 Apr 01; 86(4):e90-e96. PubMed ID: 33278181
    [Abstract] [Full Text] [Related]

  • 3. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
    Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER, MTN-025/HOPE Study Team.
    Lancet HIV; 2021 Feb 01; 8(2):e87-e95. PubMed ID: 33539762
    [Abstract] [Full Text] [Related]

  • 4. Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study).
    Balán IC, Giguere R, Lentz C, Kutner BA, Kajura-Manyindo C, Byogero R, Asiimwe FB, Makala Y, Jambaya J, Khanyile N, Chetty D, Soto-Torres L, Mayo A, Mgodi NM, Palanee-Phillips T, Baeten JM.
    AIDS Behav; 2021 Feb 01; 25(2):447-458. PubMed ID: 32833192
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.
    Naidoo K, T ME, Katz AW, Morgan G, Krishnaveni R, Lydia ST, Sarita N, Leila ME.
    AIDS Behav; 2023 Jan 01; 27(1):75-81. PubMed ID: 35672549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study.
    Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T.
    AIDS Behav; 2022 Mar 01; 26(3):752-763. PubMed ID: 34546473
    [Abstract] [Full Text] [Related]

  • 9. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa.
    Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A, MTN-025/HOPE Study Team.
    AIDS Behav; 2021 Dec 01; 25(12):3847-3857. PubMed ID: 34009480
    [Abstract] [Full Text] [Related]

  • 10. Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial.
    Mirembe BG, Cabrera MV, van der Straten A, Nakalega R, Cobbing M, Mgodi NM, Palanee-Phillips T, Mayo AJ, Dadabhai S, Mansoor LE, Siva S, Nair G, Chinula L, Akello CA, Nakabiito C, Soto-Torres LE, Baeten JM, Brown ER.
    AIDS Behav; 2023 Mar 01; 27(3):1030-1043. PubMed ID: 36066762
    [Abstract] [Full Text] [Related]

  • 11. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention.
    Husnik MJ, Brown ER, Dadabhai SS, Gaffoor Z, Jeenarain N, Kiweewa FM, Livant E, Mansoor LE, Mirembe BG, Palanee-Phillips T, Singh D, Siva S, Soto-Torres L, van der Straten A, Baeten JM, M. T. N.-020/ASPIRE Study Team.
    AIDS Behav; 2021 Sep 01; 25(9):2801-2814. PubMed ID: 34117592
    [Abstract] [Full Text] [Related]

  • 12. Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
    Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S, Gafoor Z, Pather A, Matovu F, Hlahla K, Makanani B, Nair G, Schwartz K, Torjesen K, Brown E, Soto-Torres L, Baeten J, Montgomery ET.
    J Acquir Immune Defic Syndr; 2018 Dec 15; 79(5):580-589. PubMed ID: 30239426
    [Abstract] [Full Text] [Related]

  • 13. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.
    Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams.
    AIDS Behav; 2022 May 15; 26(5):1597-1606. PubMed ID: 34727272
    [Abstract] [Full Text] [Related]

  • 14. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study.
    Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, Kemigisha D, Musara P, Mansoor LE, Singh N, Woeber K, Morar NS, Jeenarain N, Gaffoor Z, Gondwe DK, Makala Y, Fleurs L, Reddy K, Palanee-Phillips T, Baeten JM, van der Straten A, Soto-Torres L, Torjesen K.
    BMC Public Health; 2021 Nov 08; 21(1):2041. PubMed ID: 34749675
    [Abstract] [Full Text] [Related]

  • 15. Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey.
    Stalter RM, Tharaldson J, Owen DH, Okumu E, Moench T, Mack N, Tolley EE, MacQueen KM.
    PLoS One; 2017 Nov 08; 12(7):e0180963. PubMed ID: 28708847
    [Abstract] [Full Text] [Related]

  • 16. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
    Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A, Steytler J, van der Ryst E, Craig C, Louw C, Gwetu T, Mabude Z, Kotze P, Moraba R, Tempelman H, Gill K, Kusemererwa S, Bekker LG, Devlin B, Rosenberg Z, DREAM Study Team.
    Lancet HIV; 2021 Feb 08; 8(2):e77-e86. PubMed ID: 33539761
    [Abstract] [Full Text] [Related]

  • 17. Women's motivations for participating in the dapivirine vaginal ring open label extension study.
    Naidoo K, Montgomery ET, Katz AWK, Garcia M, Naidoo S, Mansoor LE.
    AIDS Care; 2024 Mar 08; 36(3):326-342. PubMed ID: 37734338
    [Abstract] [Full Text] [Related]

  • 18. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
    Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET, for the MTN-020/ASPIRE Team.
    AIDS Behav; 2020 May 08; 24(5):1432-1442. PubMed ID: 31667678
    [Abstract] [Full Text] [Related]

  • 19. The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention.
    Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, Zimba C, Montgomery ET.
    AIDS Behav; 2020 Aug 08; 24(8):2387-2399. PubMed ID: 31980993
    [Abstract] [Full Text] [Related]

  • 20. Male Partner Opinions of the Dapivirine Vaginal Ring Used During an Open-Label Extension HIV Prevention Trial in KwaZulu-Natal, South Africa.
    Morar NS, Mansoor LE, Naidoo K, Katz AWK, Garcia M, Duma C, Precious Myeni NB, Tshbalala T, Naidoo S, Montgomery ET.
    J Acquir Immune Defic Syndr; 2023 Feb 01; 92(2):127-133. PubMed ID: 36302179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.